These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33822783)

  • 1. Utility of Fatty Liver Index to predict reversion to normoglycemia in people with prediabetes.
    Busquets-Cortés C; Bennasar-Veny M; López-González ÁA; Fresneda S; Abbate M; Yáñez AM
    PLoS One; 2021; 16(4):e0249221. PubMed ID: 33822783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study.
    Wargny M; Smati S; Pichelin M; Bigot-Corbel E; Authier C; Dierry V; Zaïr Y; Jacquin V; Hadjadj S; Boursier J; Cariou B
    PLoS One; 2019; 14(8):e0221524. PubMed ID: 31465427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes.
    Bennasar-Veny M; Fresneda S; López-González A; Busquets-Cortés C; Aguiló A; Yañez AM
    Nutrients; 2020 May; 12(5):. PubMed ID: 32466178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of lifestyle interventions in the reversion to normoglycemia in Korean prediabetics: One-year results from a randomised controlled trial.
    Nah EH; Chu J; Kim S; Cho S; Kwon E
    Prim Care Diabetes; 2019 Jun; 13(3):212-220. PubMed ID: 30583933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
    Franch-Nadal J; Caballeria L; Mata-Cases M; Mauricio D; Giraldez-García C; Mancera J; Goday A; Mundet-Tudurí X; Regidor E;
    PLoS One; 2018; 13(6):e0198327. PubMed ID: 29856820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneity of reversion to normoglycemia according to prediabetes type is not explained by lifestyle factors.
    Giráldez-García C; Cea-Soriano L; Albaladejo R; Franch-Nadal J; Mata-Cases M; Díez-Espino J; Artola S; Serrano R; Regidor E;
    Sci Rep; 2021 May; 11(1):9667. PubMed ID: 33958606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study.
    Vistisen D; Kivimäki M; Perreault L; Hulman A; Witte DR; Brunner EJ; Tabák A; Jørgensen ME; Færch K
    Diabetologia; 2019 Aug; 62(8):1385-1390. PubMed ID: 31123789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical Activity and Improvement of Glycemia in Prediabetes by Different Diagnostic Criteria.
    Færch K; Witte DR; Brunner EJ; Kivimäki M; Tabák A; Jørgensen ME; Ekelund U; Vistisen D
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3712-3721. PubMed ID: 28973497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes.
    Busquets-Cortés C; Bennasar-Veny M; López-González AA; Fresneda S; Aguiló A; Yanez A
    BMJ Open; 2021 Aug; 11(8):e045498. PubMed ID: 34433590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Link between remnant cholesterol and the reversion to normoglycemia in Chinese adults with prediabetes: a 5-year cohort study.
    Chen W; Hu H; Cao C; Liu D; Han Y
    Sci Rep; 2024 Aug; 14(1):18098. PubMed ID: 39103476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Death Associated With Reversion From Prediabetes to Normoglycemia and the Role of Modifiable Risk Factors.
    Cao Z; Li W; Wen CP; Li S; Chen C; Jia Q; Li W; Zhang W; Tu H; Wu X
    JAMA Netw Open; 2023 Mar; 6(3):e234989. PubMed ID: 36976559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classifying and communicating risks in prediabetes according to fasting glucose and/or glycated hemoglobin: PREDAPS cohort study.
    Regidor E; Cea-Soriano L; Ruiz A; Goday A; Carabantes D; Díez-Espino J; Artola S; Franch-Nadal J;
    Scand J Prim Health Care; 2021 Sep; 39(3):355-363. PubMed ID: 34348071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
    Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
    J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Steatosis and High-Normal Fasting Glucose as Risk Factors for Incident Prediabetes.
    Aizawa T; Nakasone Y; Murai N; Oka R; Nagasaka S; Yamashita K; Sakuma T; Kiyosawa K
    J Endocr Soc; 2022 Sep; 6(9):bvac110. PubMed ID: 35958436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between body mass index and reversion to normoglycemia from impaired fasting glucose among Chinese adults: a 5-year cohort study.
    Han Y; Hu H; Huang Z; Liu D
    Front Endocrinol (Lausanne); 2023; 14():1111791. PubMed ID: 37143738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
    Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
    J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the role of atherogenic index of plasma in the reversion from Prediabetes to normoglycemia or progression to Diabetes: a multi-center retrospective cohort study.
    Yang H; Kuang M; Yang R; Xie G; Sheng G; Zou Y
    Cardiovasc Diabetol; 2024 Jan; 23(1):17. PubMed ID: 38184569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness of Prediabetes Status and Subsequent Health Behavior, Body Weight, and Blood Glucose Levels.
    Owei I; Umekwe N; Ceesay F; Dagogo-Jack S
    J Am Board Fam Med; 2019; 32(1):20-27. PubMed ID: 30610138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of lifestyle intervention in the reversion to normoglycemia in people with prediabetes.
    Liu Y; Guo H; Wang Q; Chen J; Xuan Y; Xu J; Liu Y; Sun K; Gao Q; Sun Z; Wang B
    Prim Care Diabetes; 2022 Feb; 16(1):168-172. PubMed ID: 34930688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Prediabetes Status Among Adults During a 6-Month Randomized Placebo-controlled Supplement Trial With Nutrition and Lifestyle Counselling and 6-Month Follow-up.
    Bessell E; Markovic TP; Caterson ID; Fuller NR
    Can J Diabetes; 2023 Oct; 47(7):571-578. PubMed ID: 37187439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.